GASTON-DREYFUS REMI reported 1 transaction at BIONIK LABORATORIES CORP.
Review the transaction codes below to understand the nature of each event.
Filed: 6/21/2022ACC: 0001104659-22-073083
Director10% Owner
Since Jul 2018
+77.89K
Net shares
Net buyer
$739.9K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
77.89K acquired
Non-Derivative Transactions1
Common Stock, par value $0.001 per share
Indirect
Shares
+77.89K
Price / share
$9.50
Trade value
$739.93K
% of position
5.1%
3/31/2022
1.54M→1.62M
Total
Net shares
+77.89K
Net value
$739.93K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 per share Indirect | 3/31/2022 | C · Conversion | +77.89K | $9.50 | $739.93K | 5.1% | 1.54M | 1.62M |
| Total | +77.89K | $739.93K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock, par value $0.001 per share
DirectShares owned61.26K
Total
61.26K direct61.26K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, par value $0.001 per share | 61.26K | Direct |
| Total | 61.26K | 61.26K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported